As a metric for ALL aggressiveness, FOXM1 mRNA expression levels also correlated with time to relapse (Fig. 3a; n=52; P=0.00015; Kruskal–Wallis rank-sum test). Here, FOXM1 is linked to acute lymphoblastic leukemia.